The compensation plan for victims of a Héma-Québec product provides compensation to any individual whose health has been seriously affected by a defective or contaminated product distributed by Héma-Québec, despite all safety measures established.
Among other things, Héma-Québec distributes blood products, human tissue, stem cells and breast milk.
All products distributed by Héma-Québec are covered by the plan, with the exception of the following:
- Products used for research purposes or for clinical trials, unless notice to the contrary is given by the Minister of Health and Social Services.
- Products developed from a human biological product excluded from the compensation plan by the Government of Québec. This exclusion also applies to products that could be added to Héma-Québec’s mandate and could potentially be manufactured from excluded human biological products.
Last update: May 6, 2019